These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38795804)

  • 21. Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey.
    Hatz MH; Schreyögg J; Torbica A; Boriani G; Blankart CR
    Health Econ; 2017 Feb; 26 Suppl 1():124-144. PubMed ID: 28139093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
    Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
    Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India.
    Dabak SV; Pilasant S; Mehndiratta A; Downey LE; Cluzeau F; Chalkidou K; Luz ACG; Youngkong S; Teerawattananon Y
    Health Res Policy Syst; 2018 Nov; 16(1):115. PubMed ID: 30486827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In perspective: new medical devices and improved patient outcome.
    Caldwell MA
    Prog Cardiovasc Nurs; 1995; 10(2):23-7. PubMed ID: 7651946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review.
    Jiang X; Ming WK; You JH
    J Med Internet Res; 2019 Jun; 21(6):e13166. PubMed ID: 31210136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana.
    Gad M; Lord J; Chalkidou K; Asare B; Lutterodt MG; Ruiz F
    Value Health; 2020 Feb; 23(2):171-179. PubMed ID: 32113622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
    Shiroiwa T; Fukuda T; Ikeda S; Takura T
    Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.
    Polisena J; Castaldo R; Ciani O; Federici C; Borsci S; Ritrovato M; Clark D; Pecchia L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):276-289. PubMed ID: 29909792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of model-based analyses reporting the cost-effectiveness and cost-utility of cardiovascular disease management programs.
    Maru S; Byrnes J; Whitty JA; Carrington MJ; Stewart S; Scuffham PA
    Eur J Cardiovasc Nurs; 2015 Feb; 14(1):26-33. PubMed ID: 24836972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding cost effectiveness: money matters?
    Sprague S; Quigley L; Adili A; Bhandari M
    J Long Term Eff Med Implants; 2007; 17(2):145-52. PubMed ID: 18540857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.
    Mathes T; Jacobs E; Morfeld JC; Pieper D
    BMC Health Serv Res; 2013 Sep; 13():371. PubMed ID: 24079858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual health services.
    Schnell-Inderst P; Hunger T; Hintringer K; Schwarzer R; Seifert-Klauss VR; Gothe H; Wasem J; Siebert U
    GMS Health Technol Assess; 2011; 7():Doc05. PubMed ID: 21966301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Benefit assessments for medical technology devices: Strategic challenges for clinical research].
    Schönermark MP
    HNO; 2015 Aug; 63(8):586-8. PubMed ID: 26204843
    [No Abstract]   [Full Text] [Related]  

  • 37. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone graft substitutes for the treatment of traumatic fractures of the extremities.
    Hagen A; Gorenoi V; Schönermark MP
    GMS Health Technol Assess; 2012; 8():Doc04. PubMed ID: 22984371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-analytic modeling for early health technology assessment of medical devices - a scoping review.
    Conrads-Frank A; Schnell-Inderst P; Neusser S; Hallsson LR; Stojkov I; Siebert S; Kühne F; Jahn B; Siebert U; Sroczynski G
    Ger Med Sci; 2022; 20():Doc11. PubMed ID: 36742459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.